CELCUITY INC. Increase (Decrease) in Other Current Assets
CELCUITY INC. (CELC) reported Increase (Decrease) in Other Current Assets of $3.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-13
- CELCUITY INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $2.58M, a 762.54% increase year-over-year.
- CELCUITY INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $976.00K, a 206.92% increase year-over-year.
- CELCUITY INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$7.71M.
- CELCUITY INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was $10.08M.
- CELCUITY INC. increase (decrease) in other current assets for fiscal 2025 was $2.99M.
- CELCUITY INC. increase (decrease) in other current assets for fiscal 2024 was -$2.77M, a 180.57% decline from fiscal 2023.
- CELCUITY INC. increase (decrease) in other current assets for fiscal 2023 was $3.44M, a 37.79% decline from fiscal 2022.
- CELCUITY INC. increase (decrease) in other current assets for fiscal 2022 was $5.53M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 9 month as first filed | Increase (Decrease) in Other Current Assets 12 month | Increase (Decrease) in Other Current Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $3.56M 10-Q · filed 2026-08-13 | -$4.15M derived: sum of 3 quarters · filed 2026-08-13 | $5.93M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $976.00K 10-Q · filed 2026-05-14 | -$6.73M derived: sum of 2 quarters · filed 2026-05-14 | $3.35M derived: sum of 3 quarters · filed 2026-05-14 | $3.65M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $2.37M derived: sum of 2 quarters · filed 2026-03-26 | $2.67M derived: sum of 3 quarters · filed 2026-08-13 | $2.99M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $10.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $10.38M derived: sum of 2 quarters · filed 2026-08-13 | $10.70M 10-Q · filed 2025-11-13 | $9.67M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $617.00K 10-Q · filed 2026-08-13 | $5.25M 10-Q · filed 2025-08-14 | -$412.00K derived: sum of 3 quarters · filed 2026-08-13 | -$682.00K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $318.00K 10-Q · filed 2026-05-14 | $2.44M 10-Q · filed 2025-05-15 | -$711.00K derived: sum of 2 quarters · filed 2026-05-14 | -$981.00K derived: sum of 3 quarters · filed 2026-05-14 | -$2.18M derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.30M derived: sum of 2 quarters · filed 2026-03-26 | -$2.50M derived: sum of 3 quarters · filed 2026-03-26 | -$2.77M 10-K · filed 2026-03-26 | -$775.98K 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.47M derived: sum of 2 quarters · filed 2025-11-13 | -$1.74M 10-Q · filed 2025-11-13 | -$1.74M 10-Q · filed 2024-11-14 | $631.29K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.47M 10-Q · filed 2025-08-14 | -$1.47M 10-Q · filed 2024-08-14 | $901.29K derived: sum of 3 quarters · filed 2025-08-14 | $2.05M derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$269.00K 10-Q · filed 2025-05-15 | -$268.85K 10-Q · filed 2024-05-15 | $2.10M derived: sum of 2 quarters · filed 2025-05-15 | $3.26M derived: sum of 3 quarters · filed 2025-05-15 | $3.15M derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.52M derived: sum of 2 quarters · filed 2025-03-31 | $3.42M derived: sum of 3 quarters · filed 2025-03-31 | $3.44M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.05M derived: sum of 2 quarters · filed 2024-11-14 | $1.07M 10-Q · filed 2024-11-14 | $774.38K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$102.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$86.67K 10-Q · filed 2024-08-14 | -$378.02K derived: sum of 3 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $15.81K 10-Q · filed 2024-05-15 | -$275.55K derived: sum of 2 quarters · filed 2024-05-15 | ||||||
| 2022-12-31 | -$291.36K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $5.53M 10-K · filed 2024-03-27 | ||||||
| 2022-09-30 | $5.82M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |